Tratamento do Câncer de Cabeça e Pescoço Localmente Avançado com Quimioterapia Pré-Operatória ou Pré-Radioterapia

Autores/as

  • Mônica E. Stramare Pereira Oncologista Clínico. Hospital Evangélico e Centro de Oncologia. Curitiba (PR), Brasil
  • Raphael Semchechen Filho Cirurgião de Cabeça e Pescoço. Hospital Evangélico e Centro de Oncologia. Curitiba (PR), Brasil
  • Marilene L. Madsen Cunha Oncologista Clínico. Hospital Evangélico E Centro De Oncologia. Curitiba (PR), Brasil

DOI:

https://doi.org/10.32635/2176-9745.RBC.1986v32n3.3267

Palabras clave:

Câncer de Cabeça e Pescoço, Quimioterapia

Resumen

Os autores analisam os 25 casos considerados avaliáveis, dos 51 incluídos no estudo, nos quais se utilizou quimioterapia com cisplatinum, mitomicina-C e bleomicina, em esquema ambulatorial, em pacientes virgens de tratamento. Obteve-se 4% de resposta completa (RC), 64% de resposta parcial (RP), 20% de estabilização da doença (ED) e 12% de sem resposta (SR). A sobrevida média dos casos que obtiveram resposta objetiva (RC+RP) foi de 8,2 meses, que foi igual à encontrada no grupo que ná0 respondeu satisfatoriamente (ED+SR). A sobrevida de um grupo-controle histórico submetido apenas à radioterapia e/ou cirurgia foi de 8,8 meses. A diferença não foi significativa.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Cachin Y, Eschwege F: Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer treat. Rev. 1975; 2: 177-91. DOI: https://doi.org/10.1016/S0305-7372(75)80002-8

Probert JC, Thompson RW, Bagshaw MA: Patterns of spread of distant metastases in head and neck cancer. Cancer. 1974; 33: 127-33. DOI: https://doi.org/10.1002/1097-0142(197401)33:1<127::AID-CNCR2820330119>3.0.CO;2-L

Leone LA, Albala MM, Rege vB: Treatment of carcinoma of the head and neck with intravenous methotrexate. cancer, 1968; 21: 828-37. DOI: https://doi.org/10.1002/1097-0142(196805)21:5<828::AID-CNCR2820210507>3.0.CO;2-Q

Carter SK: The chemotherapy of head and neck cancer. Semin. Oncol. 1977; 4: 413-24.

Hong WK: Schaefer S, Issel B, et al. A prospective randomized trial of Methotrexate versus cispiatinum in the treatment of recurrent squamous celi carcinoma of the head and neck. Proc. Am. Soc. Clin. Oncol. 1982; 1: 202. (Abstract)

Blum RH Carter SK, Agre K: A clinical review of Bleomycin-A new antineoplastic agent Cancer. 1973; 31: 903-914. DOI: https://doi.org/10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N

Woods RL, Foy RM, Tatter Sali, MHN: Methotrexate treatment for squamous cell head and neck cancer: dose response evaluation. Brit Med. J. 1972; 282: 600-602. DOI: https://doi.org/10.1136/bmj.282.6264.600

Hong WK, Bromer R: chemotherapy in head and neck cancer. N. Engl. J. Med. 1983; 308: 75-79. DOI: https://doi.org/10.1056/NEJM198301133080204

UICC (Union internationale Contre le Cancer). TNM - Classification of Malignant Tumors, 3 ed, M.H. Harmer, Geneva; 1978; 17-38.

Israel L, et al: Head and Neck Cancers - 57 Patients treated with Cisplatinum and continuous Bieomycin; 53 pacients treated with Cispiatinum, Mitomycin-C and continuous Bleomycin. Proc. Am. Soc. Clin. Oncol. 1982; 1: C-779.

Kraut M, et al: Cispiatinum, Bieomycin and Methotrexate therapy prior to surgery and radiation in advanced squamous cell carcinoma of the head and neck. Proc. Am. Soc. Clin. Oncol. 1982; 1 C-760.

Glick JH, et al: The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and Bleomycin infusions prior to definitive radioterapy Cancer, 1980; 46(9): 1919-1924. DOI: https://doi.org/10.1002/1097-0142(19801101)46:9<1919::AID-CNCR2820460905>3.0.CO;2-X

Waif GT, Makuch RW: Preoperative Cis-diamine Dichoride Platinum (II) and Bleomycin in pacients with head and neck squamous carcinoma: toxicity and tumor response. Proc. Am. Assoc. Cancer Res. 1980; 21: 400.

Glick JH, et e al: Adjuvant treatment of inoperable stage III and stage IV epidermoid carcinoma of the head anc neck with Platinum and Bleomycin infusions prior to definitive radiotherapy; a Radiation Therapy Oncology group Pilot Study. Proc. Am. Assoc. Cancer Res. 1980; 21: 473. DOI: https://doi.org/10.1016/0360-3016(79)90504-2

Al-Sarraf et al: The adjuvant use of Cis-Piatinum, Oncovin and Bieomycin (COB) prior to surgery and/or radiotherapy in untreated epidermoid cancer of the head and Neck. Adjuvant Therapy of Cancer II, Proceedings of the Second international Conference on the adjuvant Therapy of Cancer Held in Tucson, AZ, 28-31 March, 1979. Jones SE, Salmon S.E. ed New York, Grune and Stratton, 674 p.p., 1979.

Penacchio TL et al: Combination of cisplatinum and Bleomycin prior to surgery and/or radiotherapy alone for treatment of advanced squamous cell carcinoma of the head neck, Cancer. 1982; 59: 2795-2801, DOI: https://doi.org/10.1002/1097-0142(19821215)50:12<2795::AID-CNCR2820501218>3.0.CO;2-0

Rooney M, et al: improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120-ham, S/FU infusion and cis-Platinum. Cancer. 1985; 1123-1128. DOI: https://doi.org/10.1002/1097-0142(19850301)55:5<1123::AID-CNCR2820550530>3.0.CO;2-8

Publicado

2023-08-07

Cómo citar

1.
Pereira MES, Semchechen Filho R, Cunha MLM. Tratamento do Câncer de Cabeça e Pescoço Localmente Avançado com Quimioterapia Pré-Operatória ou Pré-Radioterapia. Rev. Bras. Cancerol. [Internet]. 7 de agosto de 2023 [citado 23 de diciembre de 2024];32(3):223-7. Disponible en: https://rbc.inca.gov.br/index.php/revista/article/view/3267

Número

Sección

ARTÍCULO ORIGINAL